Center for Scientific Review; Notice of Closed Meetings, 20375 [2021-07981]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 73 / Monday, April 19, 2021 / Notices
ACTION:
Notice of meeting.
As required by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services (HHS) is hereby giving notice
that the COVID–19 Health Equity Task
Force (Task Force) will hold a virtual
meeting on April 30, 2021. The purpose
of this meeting is to consider interim
recommendations specific to mental and
behavioral health across the life course.
This meeting is open to the public and
will be live-streamed at www.hhs.gov/
live. Information about the meeting will
be posted on the HHS Office of Minority
Health website:
www.minorityhealth.hhs.gov/
healthequitytaskforce/ prior to the
meeting.
DATES: The Task Force meeting will be
held on Friday, April 30, 2021, from 2
p.m. to approximately 6 p.m. ET (date
and time are tentative and subject to
change). The confirmed time and
agenda will be posted on the COVID–19
Health Equity Task Force web page:
www.minorityhealth.hhs.gov/
healthequitytaskforce/ when this
information becomes available.
FOR FURTHER INFORMATION CONTACT:
Minh Wendt, Designated Federal Officer
for the Task Force; Office of Minority
Health, Department of Health and
Human Services, Tower Building, 1101
Wootton Parkway, Suite 100, Rockville,
Maryland 20852. Phone: 240–453–6160;
email: COVID19HETF@hhs.gov.
SUPPLEMENTARY INFORMATION:
Background: The COVID–19 Health
Equity Task Force (Task Force) was
established by Executive Order 13995,
dated January 21, 2021. The Task Force
is tasked with providing specific
recommendations to the President,
through the Coordinator of the COVID–
19 Response and Counselor to the
President (COVID–19 Response
Coordinator), for mitigating the health
inequities caused or exacerbated by the
COVID–19 pandemic and for preventing
such inequities in the future. The Task
Force shall submit a final report to the
COVID–19 Response Coordinator
addressing any ongoing health
inequities faced by COVID–19 survivors
that may merit a public health response,
describing the factors that contributed to
disparities in COVID–19 outcomes, and
recommending actions to combat such
disparities in future pandemic
responses.
The meeting is open to the public and
will be live-streamed at www.hhs.gov/
live. No registration is required. A
public comment session will be held
during the meeting. Pre-registration is
required to provide public comment
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:11 Apr 16, 2021
Jkt 253001
20375
during the meeting. To pre-register,
please send an email to
COVID19HETF@hhs.gov and include
your name, title, and organization by
close of business on Friday, April 23,
2021. Comments will be limited to no
more than three minutes per speaker
and should be pertinent to the meeting
discussion. Individuals are encouraged
to provide a written statement of any
public comment(s) for accurate minutetaking purposes. If you decide you
would like to provide public comment
but do not pre-register, you may submit
your written statement by emailing
COVID19HETF@hhs.gov no later than
close of business on Thursday, May 6,
2021. Individuals who plan to attend
and need special assistance, such as
sign language interpretation or other
reasonable accommodations, should
contact: COVID19HETF@hhs.gov and
reference this meeting. Requests for
special accommodations should be
made at least 10 business days prior to
the meeting.
Contact Person: Svetlana Kotliarova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
Bethesda, MD 20892, 301–594–7945,
kotliars@mail.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Cancer Prevention Study Section.
Date: June 17–18, 2021.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Svetlana Kotliarova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
Bethesda, MD 20892, 301–594–7945,
kotliars@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 5, 2021.
Minh Wendt,
Designated Federal Officer, COVID–19 Health
Equity Task Force.
Dated: April 14, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–08002 Filed 4–16–21; 8:45 am]
[FR Doc. 2021–07981 Filed 4–16–21; 8:45 am]
BILLING CODE 4150–29–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Substance Abuse and Mental Health
Services Administration
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; NIH
Research Enhancement Award (R15) in
Oncological Sciences.
Date: May 26, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
PO 00000
Frm 00015
Fmt 4703
Sfmt 4703
Advisory Committee for Women’s
Services (ACWS); Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given of a meeting of
the Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Advisory Committee for Women’s
Services (ACWS) on May 5, 2021.
The meeting will include discussions
on assessing SAMHSA’s current
strategies, including the mental health
and substance use needs of the women
and girls population. Additionally, the
ACWS will be addressing priorities
regarding the impact of COVID–19 on
the behavioral health needs of women
and children and directions around
behavioral health services and access for
women and children.
The meeting is open to the public and
will be held virtually. Interested persons
may present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions should be forwarded to the
contact person by April 30, 2021. Oral
presentations from the public will be
scheduled at the conclusion of the
E:\FR\FM\19APN1.SGM
19APN1
]]>Agencies
[Federal Register Volume 86, Number 73 (Monday, April 19, 2021)]
[Notices]
[Page 20375]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-07981]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; NIH Research Enhancement Award (R15) in Oncological Sciences.
Date: May 26, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Svetlana Kotliarova, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214, Bethesda, MD 20892, 301-
594-7945, [email protected].
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Cancer Prevention Study Section.
Date: June 17-18, 2021.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Svetlana Kotliarova, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214, Bethesda, MD 20892, 301-
594-7945, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: April 14, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-07981 Filed 4-16-21; 8:45 am]
BILLING CODE 4140-01-P
